IP Library Granted Patent US 12,188,068
Granted Patent B2
US 12,188,068 · App. 17/229,543 · Granted Jan 7, 2025

Semisynthetic routes to organic compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,188,068
App. No.
17/229,543
Granted
Jan 7, 2025
Kind
B2
Abstract

The present disclosure relates to chemo-enzymatic processes for the preparation of lactones (including, e.g., macrolactones, γ-lactones, and δ-lactones) and/or macrocyclic ketones, which are compounds of industrial value, for example, for use as fragrance ingredients. The chemo-enzymatic processes combine the in vivo microbial production of fatty acid derivatives and the subsequent ex vivo synthetic transformation of the fatty acid derivatives to provide the lactones and macrocyclic ketones.

Claims (30)

1. A chemo-enzymatic process for producing Z-9 cyclohexadecenolide having the chemical structure:

the process comprising:

(i) culturing a recombinant microorganism in the presence of a carbon-based feedstock, wherein

the recombinant microorganism is a bacterium, cyanobacterium, yeast, or filamentous fungus,

the recombinant microorganism is genetically engineered to overexpress or to exogenously express an ω-hydroxylase or oxygenase of E.C. 1.14.15.3 compared to a native host cell, and

the recombinant microorganism produces an unsaturated ω-hydroxy fatty acid derivative that is ω-hydroxy-cis-9-hexadecenoic acid having the chemical structure:

and

(ii) contacting the ω-hydroxy-cis-9-hexadecenoic acid ex vivo with a reagent under conditions sufficient to produce the Z-9 cyclohexadecenolide, wherein the contacting comprises dehydration, lactonization, or a combination thereof.

2. The chemo-enzymatic process of claim 1 , wherein the recombinant microorganism is further engineered to overexpress or exogenously express a thioesterase.

3. The chemo-enzymatic process of claim 1 , wherein the recombinant microorganism is further engineered to overexpress a desaturase (EC 1.14.19).

4. The chemo-enzymatic process of claim 1 , wherein the recombinant microorganism is a recombinant Escherichia coli ( E. coli ).

5. The chemo-enzymatic process of claim 1 , further comprising isolating the ω-hydroxy-cis-9-hexadecenoic acid prior to the contacting.

6. The chemo-enzymatic process of claim 1 , wherein the ω-hydroxy -cis-9-hexadecenoic acid is secreted from the recombinant microorganism and the contacting is performed without isolating the ω-hydroxy-cis-9-hexadecenoic acid.

7. The chemo-enzymatic process of claim 1 , wherein the carbon-based feedstock comprises a simple carbon source.

8. The chemo-enzymatic process of claim 1 , wherein the carbon-based feedstock is renewable.

9. The chemo-enzymatic process of claim 1 , wherein the reagent comprises a Lewis acid.

10. The chemo-enzymatic process of claim 9 , wherein the Lewis acid is an organostannane transesterification catalyst, a copper salt, a zinc salt, a silver triflate, or a zeolite.

11. The chemo-enzymatic process of claim 1 , wherein the reagent comprises a protic acid.

12. The chemo-enzymatic process of claim 11 , wherein the protic acid is hydrochloric acid, sulfuric acid, phosphoric acid, or a recoverable resin acid.

13. The chemo-enzymatic process of claim 1 , wherein the Z-9 cyclohexadecenolide is a fragrance ingredient.

14. The chemo-enzymatic process of claim 1 , wherein the reagent comprises a peptide coupling agent.

15. A chemo-enzymatic process for producing a fragrance or perfume comprising Z-9 cyclohexadecenolide having the chemical structure:

the process comprising:

(i) culturing a recombinant microorganism in the presence of a carbon-based feedstock, wherein

the recombinant microorganism is a bacterium, cyanobacterium, yeast, or filamentous fungus,

the recombinant microorganism is genetically engineered to overexpress or to exogenously express an ω-hydroxylase or oxygenase of E.C. 1.14.15.3 compared to a native host cell, and

the recombinant microorganism produces an unsaturated ω-hydroxy fatty acid derivative that is ω-hydroxy-cis-9-hexadecenoic acid having the chemical structure:

(ii) contacting the ω-hydroxy-cis-9-hexadecenoic acid ex vivo with a reagent under conditions sufficient to produce the Z-9 cyclohexadecenolide, wherein the contacting comprises dehydration, lactonization, or a combination thereof; and

wherein the Z-9 cyclohexadecenolide is used to produce the fragrance or perfume.

16. A fragrance or perfume produced by the chemo-enzymatic process of claim 15 .

Assignments (5)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2022
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 060667/0435 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2022
From: DEL CARDAYRE, STEPHEN B.; SCHIRMER, ANDREAS W.; KO, MYONG; WANG, HAIBO
To: REG LIFE SCIENCES, LLC
Reel/Frame 060666/0080 →